$1.61
-0.035-2.13%
Last update: Nov 10, 5:35 PM
Elicio Therapeutics Inc
ELTXNASDAQ
Elicio Therapeutics fell 81.3% from $8.82 to $1.65, behind the S&P 500's +10.0%. Its worst day was Jun 15 (−72.5%), and its low came Nov 5 at $1.40.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.60 missed the $-0.54 estimate on $0.00 revenue.
−2.2% · S&P 500 0.0%
EPS of $-0.45 beat the $-0.46 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
+11.9% · S&P 500 −0.6%
EPS of $-0.65 missed the $-0.47 estimate on $0.00 revenue.
−9.1% · S&P 500 −0.2%
Elicio Therapeutics closed at its highest level of the year, 68.4% above where the year started.
+6.5% · S&P 500 +0.5%
Elicio Therapeutics shares fell 37.4%, while the S&P 500 fell 0.1%.
−37.4% · S&P 500 −0.1%
EPS of $-0.43 beat the $-0.54 estimate on $0.00 revenue.
−1.9% · S&P 500 −0.2%
EPS of $-0.30 beat the $-0.43 estimate on $0.00 revenue.
+7.9% · S&P 500 +0.3%
Where it ended: a close of $1.65 on Nov 9, 2026.
Nothing in the past 12 months.
All ELTX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ELTX and SPY from Benzinga historical bars. Not investment advice.
